Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$235K Sell
1,606
-14
-0.9% -$2.54K 0.03% 156
2026
Q1
$238K Hold
1,620
0.03% 154
2025
Q4
$316K Sell
1,620
-40
-2% -$9.52K 0.04% 137
2025
Q3
$467K Sell
1,660
-370
-18% -$94.2K 0.05% 118
2025
Q2
$444K Hold
2,030
0.05% 111
2025
Q1
$284K Buy
2,030
+245
+14% +$39.9K 0.04% 131
2024
Q4
$297K Buy
1,785
+155
+10% +$27.5K 0.04% 130
2024
Q3
$278K Hold
1,630
0.04% 139
2024
Q2
$230K Hold
1,630
0.03% 141
2024
Q1
$205K Buy
+1,630
New +$187K 0.03% 151
2019
Q3
Sell
-3,982
Closed -$227K 115
2019
Q2
$227K Sell
3,982
-999
-20% -$54.1K 0.05% 107
2019
Q1
$268K Sell
4,981
-850
-15% -$43.3K 0.06% 99
2018
Q4
$263K Buy
5,831
+844
+17% +$40.4K 0.07% 98
2018
Q3
$257K Buy
4,987
+46
+0.9% +$2.23K 0.06% 103
2018
Q2
$218K Buy
4,941
+102
+2% +$4.7K 0.06% 105
2018
Q1
$221K Sell
4,839
-197
-4% -$9.79K 0.06% 107
2017
Q4
$238K Buy
5,036
+401
+9% +$19.7K 0.07% 109
2017
Q3
$224K Hold
4,635
0.06% 109
2017
Q2
$232K Buy
4,635
+101
+2% +$4.6K 0.07% 109
2017
Q1
$202K Buy
+4,534
New +$189K 0.06% 109

Other funds holding ORCL

Baxter Bros Inc's ORCL Position: Q2 2026 in Review

Baxter Bros Inc reduced its Oracle (ORCL) stake by 0.86% in Q2 2026, selling an estimated $2.54K and leaving 1,606 shares worth $235K. The position accounts for 0.03% of the portfolio, ranked #156.

Baxter Bros Inc first reported a position in ORCL in Q1 2017 and has held it in 20 quarters since. The position peaked at $467K in Q3 2025. 3,519 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Baxter Bros Inc held 1,606 shares of Oracle worth $235K as of Q2 2026.
  • Baxter Bros Inc sold 14 Oracle shares in Q2 2026, an estimated $2.54K.
  • Oracle made up 0.03% of Baxter Bros Inc's portfolio in Q2 2026, its #156 holding.
  • Baxter Bros Inc first reported a position in Oracle in Q1 2017 and has held it in 20 quarters since.
  • Baxter Bros Inc's Oracle position peaked at $467K in Q3 2025.
  • 3,519 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Baxter Bros Inc's 13F filing for Q2 2026, filed 6 Aug 2026.